Literature DB >> 6339498

Stereochemical specificity for sterols in Saccharomyces cerevisiae.

W J Pinto, W R Nes.   

Abstract

When sterol biosynthesis in oxygen-deprived wild type Saccharomyces cerevisiae was prevented by the presence of 2,3-iminosqualene, an inhibitor of 2,3-oxidosqualene cyclase, an absolute requirement for a sterol with a 24 beta-methyl group was found. Neither the configuration nor the size of the alkyl group at C-24 could be altered. For instance, while 24 beta-methylcholesterol (22-dihydrobrassicasterol) permitted good growth, contrary to earlier work without the inhibitor no growth at all resulted from the presence of cholesterol or its 24 alpha-methyl-, 24 alpha-ethyl-, or 24 beta-ethyl derivatives (campesterol, sitosterol, and clionasterol, respectively). The only sterol lacking a 24 beta-methyl group which allowed growth was desmosterol (24-dehydro-cholesterol), but desmosterol was metabolized to 24 beta-methylcholesterol by C1-transfer and reduction. When cholesterol supported growth in the absence of the inhibitor, small amounts of endogenously synthesized 24 beta-methylsterols (ergosterol and 22-dihydroergosterol) were identified. This previously unrecognized absolute specificity for both chirality and bulk at C-24 suggests the involvement of protein binding in at least one of the roles which sterol plays in this single-celled eukaryote.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6339498

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  25 in total

1.  Ultrastructural alterations induced by two ergosterol biosynthesis inhibitors, ketoconazole and terbinafine, on epimastigotes and amastigotes of Trypanosoma (Schizotrypanum) cruzi.

Authors:  K Lazardi; J A Urbina; W de Souza
Journal:  Antimicrob Agents Chemother       Date:  1990-11       Impact factor: 5.191

2.  Sequencing, disruption, and characterization of the Candida albicans sterol methyltransferase (ERG6) gene: drug susceptibility studies in erg6 mutants.

Authors:  K L Jensen-Pergakes; M A Kennedy; N D Lees; R Barbuch; C Koegel; M Bard
Journal:  Antimicrob Agents Chemother       Date:  1998-05       Impact factor: 5.191

3.  Side-chain structural requirements for sterol-induced regulation ofPhytophthora cactorum physiology.

Authors:  W D Nes; A E Stafford
Journal:  Lipids       Date:  1984-07       Impact factor: 1.880

4.  Sterol composition of a delta 5,7-sterol-rich strain of Saccharomyces cerevisiae during batch growth.

Authors:  C Novotný; B Bĕhalová; R Struzinský; M Novák; J Zajícek
Journal:  Folia Microbiol (Praha)       Date:  1988       Impact factor: 2.099

5.  Enantioselective inhibition of squalene synthase by aziridine analogues of presqualene diphosphate.

Authors:  Ali Koohang; Jessica L Bailey; Robert M Coates; Hans K Erickson; David Owen; C Dale Poulter
Journal:  J Org Chem       Date:  2010-07-16       Impact factor: 4.354

6.  Sterol control of the phosphatidylethanolamine-phosphatidylcholine conversion in the yeast mutant GL7.

Authors:  S Kawasaki; M Ramgopal; J Chin; K Bloch
Journal:  Proc Natl Acad Sci U S A       Date:  1985-09       Impact factor: 11.205

7.  Metabolism of 2(RS),3-epiminosqualene to 24(RS),25-epiminolanosterol byGibberella fujikuroi.

Authors:  W D Nes; E J Parish
Journal:  Lipids       Date:  1988-04       Impact factor: 1.880

8.  Effects of an azasterol inhibitor of sterol 24-transmethylation on sterol biosynthesis and growth of Leishmania donovani promastigotes.

Authors:  P A Haughan; M L Chance; L J Goad
Journal:  Biochem J       Date:  1995-05-15       Impact factor: 3.857

9.  Characteristics of sterol uptake in Saccharomyces cerevisiae.

Authors:  R T Lorenz; R J Rodriguez; T A Lewis; L W Parks
Journal:  J Bacteriol       Date:  1986-09       Impact factor: 3.490

10.  Sterol synthesis and viability of erg11 (cytochrome P450 lanosterol demethylase) mutations in Saccharomyces cerevisiae and Candida albicans.

Authors:  M Bard; N D Lees; T Turi; D Craft; L Cofrin; R Barbuch; C Koegel; J C Loper
Journal:  Lipids       Date:  1993-11       Impact factor: 1.880

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.